Bridging cardiovascular and liver disease to improve outcomes through integrated, evidence-based care.
Office bearers
Prof. Manhal Izzy
Chair
MD, Professor, Vanderbilt University · Hepatology
Prof. Sanjaya Satapathy
Secretary
Why this SIG, right now
The burden of cardio-hepatic disease is rising rapidly, driven by aging populations, increasing prevalence of heart failure, and the global epidemic of metabolic dysfunction.
Three key forces make this a pivotal moment:
Conditions such as:
Patients with combined cardiac and liver disease present unique challenges:
Decisions regarding:
Join Cardio-Hepatic Special Interest Group to read and participate in the discussion board.
Sign In